Susan G. Kozauer, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Susan G. Kozauer, M.D.
Lb Pharmaceuticals Inc reported in an 8-K filed September 15, 2026 that Susan G. Kozauer, M.D. was appointed Chief Medical Officer, effective September 14, 2026.
“On September 15, 2026, LB Pharmaceuticals Inc (the "Company") announced that Susan G. Kozauer, M.D. has been appointed to serve as the Company's Chief Medical Officer, effective as of September 14, 2026 (the "Start Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lb Pharmaceuticals Inc (LBRX)
SEC 8-K
Current2026-09-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lb Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Heather Turner CEO, Board Member
- Joseph M. Miller CFO
- Gad Soffer COO
- Robert A. Lenz Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.